[The treatment of coronary blood flow disorders with nyxanthan base compounds].
D001463:Barbiturates / Q000627:therapeutic use*; D003327:Coronary Disease / Q000628:therapy*; D004232:Diuretics; D004791:Enzyme Inhibitors; D006801:Humans; D010208:Papaverine / Q000627:therapeutic use*; D013806:Theophylline / Q000627:therapeutic use*
D001463:Barbiturates; D004232:Diuretics; D004791:Enzyme Inhibitors; D013806:Theophylline; D010208:Papaverine
BARBITURATES/therapeutic use; CORONARY DISEASE/therapy; PAPAVERINE/therapeutic use; THEOPHYLLINE/therapeutic use
Zur Behandlung koronarer Durchblutungsstörungen mit Nyxanthan-Basitorien.